Clinical trial
An Open Label Study of the Effects of Eculizumab in CD59 Deficiency
NCT01579838 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Study of the Effects of Eculizumab in CD59 Deficiency
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- February 29, 2012
- Completion date
- March 31, 2013
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hemolysis